- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
PetMed Express Inc(PETS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PETS
11/13/2026: PETS (1-star) is currently NOT-A-BUY. Pass it for now.
PetMed Express is a long-standing online retailer of pet medications and health products. The company currently faces a challenging competitive landscape against larger, omni-channel e-commerce retailers, which has pressured both its growth and margins. Its primary turnaround story involves pivoting toward higher-margin telehealth services and digital wellness tools to differentiate itself. Key risks include intense pricing pressure, high customer acquisition costs, and the ongoing execution risk associated with its business transformation. The stock may suit value-oriented investors who are closely monitoring the success of its new service-led initiatives, though it remains a higher-risk play in the crowded pet health sector.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | The company is currently focused on stabilization and turnaround rather than aggressive top-line expansion. |
| Momentum investor | Weak fit | Recent price performance and market sentiment do not support a momentum-based thesis. |
| Value investor | Mixed fit | Valuation may appear attractive on a historical basis, but earnings stability remains a concern. |
| Dividend investor | Mixed fit | While the dividend has been a feature, it is subject to the company's ability to maintain sufficient free cash flow. |
| Low-risk investor | Weak fit | The volatility and competitive pressures in the pet retail space make this a higher-risk investment. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is susceptible to sharp moves based on quarterly earnings results and retail competition reports. |
| Valuation risk | Medium | Investors must weigh the potential for a turnaround against the risk of continued margin erosion. |
| Competition risk (E-commerce giants) | High | Aggressive pricing and fulfillment capabilities from larger retailers directly threaten PetMeds' core business. |
| Business quality | Medium | The company operates in a crowded space where brand loyalty is increasingly difficult to defend. |
| Dividend income | Medium / high | Dividend sustainability is tied directly to the success of current turnaround initiatives. |
| Execution risk | High | Success depends heavily on effectively executing a pivot toward pet health services. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 20.90M USD | Price to earnings Ratio - | 1Y Target Price 1.4 |
Price to earnings Ratio - | 1Y Target Price 1.4 | ||
Volume (30-day avg) 122.8K shares | Beta 0.83 | 52 Weeks Range 0.93 - 4.10 | Updated Date 11/13/2026 |
52 Weeks Range 0.93 - 4.10 | Updated Date 11/13/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.23 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Industry classification is unavailable for this snapshot.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -12.42% | Avg. Invested days 39 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Pharmacy & Retail | Sale of prescription, non-prescription pet medications, and wellness products. | The primary way the company generates revenue is by selling common pet health products online. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 16.69 | Enterprise Value 10.87M | Price to Sales(TTM) 0.13 |
Enterprise Value 10.87M | Price to Sales(TTM) 0.13 | ||
Enterprise Value to Revenue 0.07 | Enterprise Value to EBITDA 0.63 | Shares Outstanding 22.23M | Shares Floating 13.94M |
Shares Outstanding 22.23M | Shares Floating 13.94M | ||
Percent Insiders 17.31 | Percent Institutions 36.62 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

